Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

PharmaDrug signs deal to begin manufacturing potential esophageal cancer and coronavirus treatment Cepharanthine

% of readers think this story is Fact. Add your two cents.


PharmaDrug Inc (CSE:BUZZ) (OTCPINK:LMLLF) announced it has reached an agreement with Southwest Research Institute (SwRI) to initiate clinical and non-clinical manufacturing of Cepharanthine for the company’s rare cancer and infectious diseases programs. 

In connection with the company’s recent acquisition of Sairiyo Therapeutics Inc, PharmaDrug has secured an exclusive license from SwRI to develop and commercialize a novel oral formulation of Cepharanthine.  

Cepharanthine is a natural product and has been approved for more than 70 years in Japan for a variety of acute and chronic diseases. The natural product has been shown to exhibit multiple pharmacological properties including anti-oxidative, anti-inflammatory, immuno-regulatory, anti-cancer, antiviral and antiparasitic.  

READ: PharmaDrug teams up with leading DMT researcher Jimo Borjigin at the University of Michigan in new study collaboration

However, the challenge has always been Cepharanthine’s low oral bioavailability, which represents a major obstacle to realizing its full clinical potential. That is why PharmaDrug is focused on advancing the clinical development of an improved oral formulation of Cepharanthine to treat rare cancers and infectious diseases. 

Compared to generic Cepharanthine, PharmaDrug’s novel formulation has been shown in rodent and non-rodent models to possess markedly superior bioavailability, meaning it is more easily absorbed by the body. 

One potential use for a revamped Cepharanthine is a treatment for esophageal cancer, based on compelling preclinical data and a streamlined path to approval, thanks to a US Food and Drug Administration (FDA) Orphan Drug Designation.

PharmaDrug also plans to initiate high throughput studies to screen a large panel of additional cancers to identify others that are sensitive to the effects of Cepharanthine, either alone or combined with first and second-line chemotherapy drugs. 

Additionally, Cepharanthine was recently identified as the most promising of roughly 3,000 approved agents screened in differing cell culture models of the coronavirus by two independent research groups. The drug showed greater potency at inhibiting infection than existing clinical development candidates remdesivir and chloroquine, the company said. 

However, because of generic Cepharanthine’s low bioavailability, intravenous administration would normally be necessary, which makes patient access more of a hurdle. A novel oral formulation from PharmaDrug could be useful in this instance as well. 

The company said it will initiate discussions with health regulators, including the FDA and Health Canada, to determine the appropriate next steps to advance to human clinical studies that would position Cepharanthine as a potential first-in-class therapeutic against coronavirus and future pandemics.

“We are extremely excited about Cepharanthine and its immense potential,” CEO Daniel Cohen said in a statement. “We are working diligently to advance the drug for Esophageal cancer while simultaneously assessing its potential in other rare cancers. We are also determining our mode of action relating to the drug’s apparent potential in treating COVID-19.”

Contact Andrew Kessel at [email protected]
 
Follow him on Twitter @andrew_kessel

Story by ProactiveInvestors



Source: http://www.proactiveinvestors.com/companies/news/947133/pharmadrug-signs-deal-to-begin-manufacturing-potential-esophageal-cancer-and-coronavirus-treatment-cepharanthine-947133.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!


Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST

Order by Phone at 888-809-8385 or online at https://www.herbanomic.com M - F 9am to 5pm EST

Order by Phone at 888-809-8385 or online at https://www.herbanomics.com M - F 9am to 5pm EST

Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen! 
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)

Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.

Report abuse
Loading...

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.